These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9273241)

  • 21. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study].
    Ibsen H; Lindholm LH; Pedersen OL; Dahlöf B; Kjeldsen S
    Ugeskr Laeger; 2003 Jan; 165(5):459-62. PubMed ID: 12599844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Beta blockaders and the cardiovascular system].
    Romeo F
    G Clin Med; 1979 May; 60(5):319-34. PubMed ID: 39859
    [No Abstract]   [Full Text] [Related]  

  • 24. [Coraxan and atenolol: similarities and differences in correction of clinical and functional indices in therapy of patients with coronary heart disease].
    Tatarchenko IP; Pozdniakova NV; Kapelovich VIu; Biriuchenko MV
    Klin Med (Mosk); 2008; 86(3):47-51. PubMed ID: 18441705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of celiprolol and atenolol in the treatment of hypertension.
    Rosenthal F; Silke B; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():76-7. PubMed ID: 2864070
    [No Abstract]   [Full Text] [Related]  

  • 26. [The ASCOT study: the end of the treatment of hypertension with beta-blockers?].
    Filipovský J
    Vnitr Lek; 2005 Dec; 51(12):1338-40. PubMed ID: 16430099
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
    Fossum E; Moan A; Kjeldsen SE; Devereux RB; Julius S; Snapinn SM; Edelman JM; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Dahlöf B;
    J Am Coll Cardiol; 2005 Sep; 46(5):770-5. PubMed ID: 16139123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Beta-blockers in geriatrics. Results of a symposium on Tenormin].
    MMW Munch Med Wochenschr; 1983 Oct; (42 Suppl):3-22. PubMed ID: 6140638
    [No Abstract]   [Full Text] [Related]  

  • 29. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F; Ragot S; Julien J; Herpin D
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
    Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL
    J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension.
    Mettimano M; Pichetti F; Fazzari L; Migneco A; Specchia L; Romano Spica V; Savi L
    Int J Clin Pract; 2000 Sep; 54(7):424-8. PubMed ID: 11070565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R; Brocks DR
    J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should beta-blockers continue to open against hypertension?
    Sharma SK; Khanna N; Bhandari S
    Indian Heart J; 2006; 58(4):297-300. PubMed ID: 19039142
    [No Abstract]   [Full Text] [Related]  

  • 35. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
    Rossetti E; Fragasso G; Mellone R; Vanzulli A; Del Maschio A; Chierchia SL
    Cardiologia; 1999 Jul; 44(7):653-9. PubMed ID: 10476591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treating essential hypertension. Are beta blockers still first choice?].
    Rahn KH
    MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats.
    Bhadada SV; Goyal RK
    Can J Physiol Pharmacol; 2007 Aug; 85(8):831-6. PubMed ID: 17901894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atenolol use in gestosis: clinical and hemodynamic aspects].
    Shekhtman MM; Elokhina TB; Petrova SB; Sokolova MIu
    Ter Arkh; 2000; 72(10):49-52. PubMed ID: 11220877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Left ventricular hypertrophy. Recent aspects of diagnosis and therapy].
    Schmieder RE; Schneider MP
    MMW Fortschr Med; 2002 Oct; 144(42):45-6. PubMed ID: 12533997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.